Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Luba Lopatinskaya"'
Publikováno v:
Annals of Neurology, 6, 53, 819-822
In the search for proteins that might play a role in the pathogenesis of multiple sclerosis (MS), osteopontin (OPN) has been identified as the most prominent cytokine-encoding gene expressed within MS lesions. Here, we report significantly increased
Autor:
Chris H. Polman, Frederik Barkhof, Anette Hendrika Hildegard Van Boxel-Dezaire, Luba Lopatinskaya, Lex Nagelkerken, Cornelis J. Lucas
Publikováno v:
Journal of Neuroimmunology. 138:123-131
In this longitudinal study, we examined the expression of Fas, FasL, CCR3, CCR5 and CXCR3 mRNA in peripheral blood mononuclear cells (PBMCs) of secondary progressive (SP) and relapsing-remitting (RR) multiple sclerosis (MS) patients. In RR patients,
Autor:
Paul P. Tak, Lars Klareskog, Dominique Baeten, Luba Lopatinskaya, Danielle M. Gerlag, Tim Wyant, Clarissa E. Vergunst, Y. S. Lee, Huib J. Dinant, F. Van den Bosch, Eric W. Jacobson, Malcolm D. Smith
Publikováno v:
Arthritis and rheumatism, 58(7), 1931-1939. John Wiley and Sons Inc.
Objective CCR2 is a chemokine receptor expressed by monocytes, macrophages, and a subset of T cells. Its ligand, CCL2 (monocyte chemotactic protein 1), is abundantly present in the synovium of patients with rheumatoid arthritis (RA). Blocking CCR2 pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2f8e3d4e96cff315f7cd90933b90a24
https://pure.amc.nl/en/publications/modulation-of-ccr2-in-rheumatoid-arthritis-a-doubleblind-randomized-placebocontrolled-clinical-trial(074ecee1-b9bb-4cb7-9209-3c9ceda622c3).html
https://pure.amc.nl/en/publications/modulation-of-ccr2-in-rheumatoid-arthritis-a-doubleblind-randomized-placebocontrolled-clinical-trial(074ecee1-b9bb-4cb7-9209-3c9ceda622c3).html
Publikováno v:
Multiple Sclerosis, 6, 12, 704-709
TNF-α, IL-12p35, IL-12p40, IL-4, IL-10, TGF-β1, CCR3, CXCR3, CCR5, Fas and FasL mRNA levels in PBMC of 25 multiple sclerosis (MS) patients were quantified at baseline by real-time PCR according to a post-hoc study design. The baseline values of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616e1038666e9610c386d1219be41ed1
http://resolver.tudelft.nl/uuid:f4e27b4f-3b75-4a1f-9eeb-59b7f9b78b43
http://resolver.tudelft.nl/uuid:f4e27b4f-3b75-4a1f-9eeb-59b7f9b78b43
Publikováno v:
Annals of Neurology; Jun2003, Vol. 53 Issue 6, p819-822, 4p